The injection pen market is expected to reach US$ 60,332.97 million by 2028 from US$ 37,261.35 million in 2021; it is estimated to register a CAGR of 7.14% from 2022 to 2028.
Prevalence of chronic disorders and growth in strategic developments are among the key forces driving the market. However, the availability of alternative drug delivery devices and inadequate reimbursement scenario hinder the market growth.
An injection pen is a medical device used for incorporating medicine under the skin with the help of needle. The product was first used in 1980s. Injection pen is one of the best alternatives over the daily syringes. At present, injection pens are majorly used for insulin administration. Sometime injection pens are also referred as insulin pen. These injection pens have surpassed the sales of vials for insulin administration to treat diabetes type 2.
The aging population and changes in social behavior contribute to a few common and costly long-term health problems. According to the World Health Organization (WHO), the prevalence of chronic lifestyle diseases is projected to reach 57% by 2026. Emerging markets will be hit hardest, as population explosion is expected in developing countries. With the accelerating urbanization, people are more inclined toward sedentary lifestyle, which results in obesity and diabetes. Diabetes is one of the biggest global health problems of the 21st century. According to the International Diabetes Federation (IDF), the number of people with diabetes in North America was about 46 million in 2019 and is projected to increase to 62 million by 2045. The increase in disease prevalence is about 35% over the predicted period. Furthermore, other chronic conditions such as osteoporosis, cardiovascular disorders, and multiple sclerosis require frequent drug administration for treatment and disease management. As per the WHO, cardiovascular disorders are the leading cause of death—nearly 17.9 million deaths are reported every year due to cardiovascular disorders. It has become new standard for injectable drug delivery among large patient population on a global level. Moreover, it can be easily used by the large patient population with minimal training with does not require constant assistance from of healthcare professionals, owing to which injection pens are largely adopted in home healthcare settings, thereby driving its market growth.
Furthermore, the injection pen market is characterized by the presence of various market players. To increase their market share, market players take up various strategies such as product launches, regional expansion, and technological advancements. Injection pens are more involved in continuous innovation and technological advances, leading to increased acceptance among industry players. Leading players invest in R&D to develop advanced technologies and gain more revenue.
A few recent developments related to injection pen are mentioned below:
• In May 2022, FDA approved Lilly’s Mounjaro injection, the first and only glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist for the treatment of type 2 diabetes in adults. Mounjaro is available in six doses (2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg) and comes in Lilly’s well-established auto-injector pen with a pre-attached, hidden needle.
• In January 2022, SHL Medical’s partnered with Innovation Zed for connected pen injector solutions. It launched InsulCheck DOSE, a connected add-on device that transforms traditional pen injectors into smart solutions to support the monitoring of disease management regimen.
• In November 2021, Sanofi and Roche partnered to work together in France to increase the adoption of a connected add-on for disposable insulin pens. The partners will jointly develop a scientific educational program aimed at physicians and pharmacists.
• In September 2021, BIOCORP and Novo Nordisk strengthened their partnership with a new agreement on Mallya Smart Sensor with Novo Nordisk FlexTouch insulin pens. A smart sensor called Mallya attaches directly to Novo Nordisk FlexTouch insulin pens. With Mallya, patients using FlexTouch pens will be able to capture and record daily insulin injection data, which includes insulin units, as well as date and time of the drug administration. Based on the agreement, Novo Nordisk will be commercializing Mallya in Japan from the first half of 2023.
• In May 2021, Lilly collaborated internationally with leading diabetes technology companies to integrate connected insulin pen solutions for people with diabetes. The company signed strategic international agreements with four companies—DexCom, Inc.; Glooko Inc.; myDiabby Healthcare; and Roche—to advance connected solutions and streamline care for people suffering from diabetes.
Therefore, all the above-mentioned recent developments are driving the growth of injection pen market.
Type-Based Insights
Based on type, the global injection pen market is bifurcated into disposable injection pens and reusable injection pens. In 2021, the disposable injection pen segment held a larger market share and is expected to grow at a higher CAGR during 2022–2028. The most commercially available injector systems in the global market are injector pens designed for multiple doses, prefilled syringes, and autoinjectors. For example, through innovative prefilled syringes and injector pens, parenteral medication becomes quite easy and patient friendly because it relieves the patient from the burden of carrying syringes and drug vials intended for either regular/chronic use or emergencies. Additionally, the applicability of injector pens involves safety and convenience, minimization of medicament, handling and reduction of dosage errors and waste, and improved product sterility and stability. Disposable injection pens are used until the drug cartridge is empty, and then the entire unit is disposed. In diabetic patients, insulin pens assist in taking insulin more conveniently because it combines the medication and syringe in one handy unit. Certain insulin pens are disposable, so patients can trash the pen once the insulin is injected or expired. These factors are responsible for the significant growth of the segment, thereby fueling the overall market growth during the forecast period
Therapy-Based Insights
Based on therapy, the global injection pen market is segmented as diabetes therapy, growth hormone therapy, autoimmune diseases therapy, fertility therapy, cancer therapy, and Other Therapies. The diabetes therapy segment held the largest share of the market in 2021. The other therapies segment is expected to grow at the highest CAGR during the forecast period. Other therapies involve migraine therapy. Migraine is a neurological condition causing moderate to severe headaches. For instance, migraine is common, affecting 39 million individuals in the US and 1 billion people globally, as per the estimates published in Healthline Media UK Ltd press. Therefore, with a migraine self-injection pen, an individual can self-administer migraine medication by inserting it into the tissue beneath the skin. These pens on administration can either be preventive, containing medication to reduce the frequency and severity of migraine attacks, or acute attacks that help alleviate migraine headaches. Such notable developments will accelerate the overall demand for self-injection pens among individuals, fueling market growth during the forecast period.
End User-Based Insights
Based on end user, the injection pen market is segmented into hospitals & clinics, home care, and others. The hospitals segment held the largest share of the market in 2021. The homecare segment is anticipated to register the highest CAGR of 7.4% in the market during the forecast period (2022–2028). Self-injection pens under homecare settings are an effective way to minimize the costs associated with managing and treating the broad spectrum of diseases. Additionally, self-injection pens are the first choice for new and subcutaneous administration of pharmaceutical agents. Self-injection pens possess the potential to greatly improve the quality of care from the patient’s perspective. For example, self-injection pens have more flexibility regarding the place and time of treatment, thereby substantially reducing therapy costs. Therefore, medical device companies are developing innovative products for treating a broad spectrum of diseases. For example, BD’s self-injection pens provide flexible manufacturing, drug compatibility, seamless integration, and low risks among individuals. These factors are responsible for the segmental growth. Thus, hospitals are contributing a significant share to the market and the trend is expected continue during the forecast period.
TABLE OF CONTENTS
1. Introduction
1.1 Scope of Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Injection Pen Market – by Type
1.3.2 Global Injection Pen Market – by Therapy
1.3.3 Global Injection Pen Market – by End User
1.3.4 Global Injection Pen Market – by Geography
2. Injection Pen Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Injection Pen Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 South & Central America PEST Analysis
4.2.5 Middle East & Africa PEST Analysis
4.3 Expert’s Opinion
5. Injection Pen Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Prevalence of Chronic Disorders
5.1.2 Increase in Strategic Developments
5.2 Market Restraints
5.2.1 Presence of Alternative Drug Delivery Devices and Inadequate Reimbursement Scenario
5.3 Market Opportunities
5.3.1 Increase in Biologics Patent Expiry and Use of Biosimilars
5.4 Future Trends
5.4.1 Technological Advancements and Healthcare Waste Reduction
5.5 Impact Analysis
6. Injection Pen Market – Global Analysis
6.1 Global Injection Pen Market Revenue Forecast and Analysis
6.2 Global Injection Pen Market, by Geography – Forecast and Analysis
6.3 Market Positioning of Key Players
7. Global Injection Pen Market – Revenue and Forecast to 2028 – by Type
7.1 Overview
7.2 Injection Pen Market Revenue Share, by Type 2021 & 2028 (%)
7.3 Disposable Injection Pens
7.3.1 Overview
7.3.2 Disposable Injection Pens: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Reusable Injection Pens
7.4.1 Overview
7.4.2 Reusable Injection Pens: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
8. Global Injection Pen Market Analysis and Forecast to 2028 – by Therapy
8.1 Overview
8.2 Global Injection Pen Market, by Therapy 2021 & 2028 (%)
8.3 Diabetes Therapy
8.3.1 Overview
8.3.2 Diabetes Therapy: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Growth Hormone Therapy
8.4.1 Overview
8.4.2 Growth Hormone Therapy: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Autoimmune Diseases Therapy
8.5.1 Overview
8.5.2 Autoimmune Diseases Therapy: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Fertility Therapy
8.6.1 Overview
8.6.2 Fertility Therapy: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
8.7 Cancer Therapy
8.7.1 Overview
8.7.2 Cancer Therapy: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
8.8 Other Therapies
8.8.1 Overview
8.8.2 Other Therapies: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
9. Global Injection Pen Market – Revenue and Forecast to 2028 – by End User
9.1 Overview
9.2 Injection Pen Market Revenue Share, by End User 2021 & 2028 (%)
9.3 Home Care
9.3.1 Overview
9.3.2 Home Care: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Hospitals & Clinics
9.4.1 Overview
9.4.2 Hospitals & Clinics: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Others
9.5.1 Overview
9.5.2 Others: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
10. Injection Pen Market – Revenue and Forecast to 2028 – Geographic Analysis
10.1 North America: Injection Pen Market
10.1.1 Overview
10.1.2 North America: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
10.1.3 North America: Injection Pen Market, by Type, 2019–2028 (US$ Million)
10.1.3.1 North America: Injection Pen Market, by Therapy, 2019–2028 (US$ Million)
10.1.3.2 North America: Injection Pen Market, by End User, 2019–2028 (US$ Million)
10.1.4 North America: Injection Pen Market, by Country, 2021 & 2028 (%)
10.1.4.1 US: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
10.1.4.1.1 Overview
10.1.4.1.2 US: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
10.1.4.1.3 US: Injection Pen Market, by Type, 2019–2028 (US$ Million)
10.1.4.1.4 US: Injection Pen Market, by Therapy, 2019–2028 (US$ Million)
10.1.4.1.5 US: Injection Pen Market, by End User, 2019–2028 (US$ Million)
10.1.4.2 Canada: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
10.1.4.2.1 Overview
10.1.4.2.2 Canada: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
10.1.4.2.3 Canada: Injection Pen Market, by Type, 2019–2028 (US$ Million)
10.1.4.2.4 Canada: Injection Pen Market, by Therapy, 2019–2028 (US$ Million)
10.1.4.2.5 Canada: Injection Pen Market, by End User, 2019–2028 (US$ Million)
10.1.4.3 Mexico: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
10.1.4.3.1 Overview
10.1.4.3.2 Mexico: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
10.1.4.3.3 Mexico: Injection Pen Market, by Type, 2019–2028 (US$ Million)
10.1.4.3.4 Mexico: Injection Pen Market, by Therapy, 2019–2028 (US$ Million)
10.1.4.3.5 Mexico: Injection Pen Market, by End User, 2019–2028 (US$ Million)
10.2 Europe: Injection Pen Market
10.2.1 Overview
10.2.2 Europe: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
10.2.3 Europe: Injection Pen Market, by Type, 2019–2028 (US$ Million)
10.2.4 Europe: Injection Pen Market, by Therapy, 2019–2028 (US$ Million)
10.2.5 Europe: Injection Pen Market, by End User, 2019–2028 (US$ Million)
10.2.6 Europe: Injection Pen Market, by Country, 2021 & 2028 (%)
10.2.6.1 Germany: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.1.1 Overview
10.2.6.1.2 Germany: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.1.3 Germany: Injection Pen Market, by Type, 2019–2028 (US$ Million)
10.2.6.1.4 Germany: Injection Pen Market, by Therapy, 2019–2028 (US$ Million)
10.2.6.1.5 Germany: Injection Pen Market, by End User, 2019–2028 (US$ Million)
10.2.6.2 UK: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.2.1 Overview
10.2.6.2.2 UK: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.2.3 UK: Injection Pen Market, by Type, 2019–2028 (US$ Million)
10.2.6.2.4 UK: Injection Pen Market, by Therapy, 2019–2028 (US$ Million)
10.2.6.2.5 UK: Injection Pen Market, by End User, 2019–2028 (US$ Million)
10.2.6.3 France: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.3.1 Overview
10.2.6.3.2 France: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.3.3 France: Injection Pen Market, by Type, 2019–2028 (US$ Million)
10.2.6.3.4 France: Injection Pen Market, by Therapy, 2019–2028 (US$ Million)
10.2.6.3.5 France: Injection Pen Market, by End User, 2019–2028 (US$ Million)
10.2.6.4 Italy: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.4.1 Overview
10.2.6.4.2 Italy: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.4.3 Italy: Injection Pen Market, by Type, 2019–2028 (US$ Million)
10.2.6.4.4 Italy: Injection Pen Market, by Therapy, 2019–2028 (US$ Million)
10.2.6.4.5 Italy: Injection Pen Market, by End User, 2019–2028 (US$ Million)
10.2.6.5 Spain: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.5.1 Overview
10.2.6.5.2 Spain: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.5.3 Spain: Injection Pen Market, by Type, 2019–2028 (US$ Million)
10.2.6.5.4 Spain: Injection Pen Market, by Therapy, 2019–2028 (US$ Million)
10.2.6.5.5 Spain: Injection Pen Market, by End User, 2019–2028 (US$ Million)
10.2.6.6 Rest of Europe: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.6.1 Overview
10.2.6.6.2 Rest of Europe: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.6.3 Rest of Europe: Injection Pen Market, by Type, 2019–2028 (US$ Million)
10.2.6.6.4 Rest of Europe: Injection Pen Market, by Therapy, 2019–2028 (US$ Million)
10.2.6.6.5 Rest of Europe: Injection Pen Market, by End User, 2019–2028 (US$ Million)
10.3 Asia Pacific: Injection Pen Market
10.3.1 Overview
10.3.2 Asia Pacific: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
10.3.3 Asia Pacific: Injection Pen Market, by Type, 2019–2028 (US$ Million)
10.3.4 Asia Pacific: Injection Pen Market, by Therapy, 2019–2028 (US$ Million)
10.3.5 Asia Pacific: Injection Pen Market, by End User, 2019–2028 (US$ Million)
10.3.6 Asia Pacific: Injection Pen Market, by Country, 2021 & 2028 (%)
10.3.6.1 China: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.1.1 Overview
10.3.6.1.2 China: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.1.3 China: Injection Pen Market, by Type, 2019–2028 (US$ Million)
10.3.6.1.4 China: Injection Pen Market, by Therapy, 2019–2028 (US$ Million)
10.3.6.1.5 China Injection Pen Market, by End User, 2019–2028 (US$ Million)
10.3.6.2 Japan: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.2.1 Overview
10.3.6.2.2 Japan: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.2.3 Japan: Injection Pen Market, by Type, 2019–2028 (US$ Million)
10.3.6.2.4 Japan: Injection Pen Market, by Therapy, 2019–2028 (US$ Million)
10.3.6.2.5 Japan: Injection Pen Market, by End User, 2019–2028 (US$ Million)
10.3.6.3 India: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.3.1 Overview
10.3.6.3.2 India: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.3.3 India: Injection Pen Market, by Type, 2019–2028 (US$ Million)
10.3.6.3.4 India: Injection Pen Market, by Therapy, 2019–2028 (US$ Million)
10.3.6.3.5 India: Injection Pen Market, by End User, 2019–2028 (US$ Million)
10.3.6.4 South Korea: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.4.1 Overview
10.3.6.4.2 South Korea: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.4.3 South Korea: Injection Pen Market, by Type, 2019–2028 (US$ Million)
10.3.6.4.4 South Korea: Injection Pen Market, by Therapy, 2019–2028 (US$ Million)
10.3.6.4.5 South Korea: Injection Pen Market, by End User, 2019–2028 (US$ Million)
10.3.6.5 Australia: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.5.1 Overview
10.3.6.5.2 Australia: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.5.3 Australia: Injection Pen Market, by Type, 2019–2028 (US$ Million)
10.3.6.5.4 Australia: Injection Pen Market, by Therapy, 2019–2028 (US$ Million)
10.3.6.5.5 Australia: Injection Pen Market, by End User, 2019–2028 (US$ Million)
10.3.6.6 Rest of Asia Pacific: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.6.1 Overview
10.3.6.6.2 Rest of Asia Pacific: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.6.3 Rest of Asia Pacific: Injection Pen Market, by Type, 2019–2028 (US$ Million)
10.3.6.6.4 Rest of Asia Pacific: Injection Pen Market, by Therapy, 2019–2028 (US$ Million)
10.3.6.6.5 Rest of Asia Pacific: Injection Pen Market, by End User, 2019–2028 (US$ Million)
10.4 Middle East & Africa Injection Pen Market
10.4.1 Overview
10.4.2 Middle East & Africa: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
10.4.3 Middle East & Africa: Injection Pen Market, by Type, 2019–2028 (US$ Million)
10.4.4 Middle East & Africa: Injection Pen Market, by Therapy, 2019–2028 (US$ Million)
10.4.5 Middle East & Africa: Injection Pen Market, by End User, 2019–2028 (US$ Million)
10.4.6 Middle East & Africa: Injection Pen Market, by Country, 2021 & 2028 (%)
10.4.6.1 South Africa: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
10.4.6.1.1 Overview
10.4.6.1.2 South Africa: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
10.4.6.1.3 South Africa: Injection Pen Market, by Type, 2019–2028 (US$ Million)
10.4.6.1.4 South Africa: Injection Pen Market, by Therapy, 2019–2028 (US$ Million)
10.4.6.1.5 South Africa: Injection Pen Market, by End User, 2019–2028 (US$ Million)
10.4.6.2 Saudi Arabia: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
10.4.6.2.1 Overview
10.4.6.2.2 Saudi Arabia: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
10.4.6.2.3 Saudi Arabia: Injection Pen Market, by Type, 2019–2028 (US$ Million)
10.4.6.2.4 Saudi Arabia: Injection Pen Market, by Therapy, 2019–2028 (US$ Million)
10.4.6.2.5 Saudi Arabia: Injection Pen Market, by End User, 2019–2028 (US$ Million)
10.4.6.3 UAE: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
10.4.6.3.1 Overview
10.4.6.3.2 UAE: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
10.4.6.3.3 UAE: Injection Pen Market, by Type, 2019–2028 (US$ Million)
10.4.6.3.4 UAE: Injection Pen Market, by Therapy, 2019–2028 (US$ Million)
10.4.6.3.5 UAE: Injection Pen Market, by End User, 2019–2028 (US$ Million)
10.4.6.4 Rest of Middle East & Africa: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
10.4.6.4.1 Overview
10.4.6.4.2 Rest of Middle East & Africa: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
10.4.6.4.3 Rest of Middle East & Africa: Injection Pen Market, by Type, 2019–2028 (US$ Million)
10.4.6.4.4 Rest of Middle East & Africa: Injection Pen Market, by Therapy, 2019–2028 (US$ Million)
10.4.6.4.5 Rest of Middle East & Africa: Injection Pen Market, by End User, 2019–2028 (US$ Million)
10.5 South & Central America Injection Pen Market
10.5.1 Overview
10.5.2 South & Central America: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
10.5.3 South & Central America: Injection Pen Market, by Type, 2019–2028 (US$ Million)
10.5.4 South & Central America: Injection Pen Market, by Therapy, 2019–2028 (US$ Million)
10.5.5 South & Central America: Injection Pen Market, by End User, 2019–2028 (US$ Million)
10.5.6 South & Central America: Injection Pen Market, by Country, 2021 & 2028 (%)
10.5.6.1 Brazil: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
10.5.6.1.1 Overview
10.5.6.1.2 Brazil: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
10.5.6.1.3 Brazil: Injection Pen Market, by Type, 2019–2028 (US$ Million)
10.5.6.1.4 Brazil: Injection Pen Market, by Therapy, 2019–2028 (US$ Million)
10.5.6.1.5 Brazil: Injection Pen Market, by End User, 2019–2028 (US$ Million)
10.5.6.2 Argentina: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
10.5.6.2.1 Overview
10.5.6.2.2 Argentina: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
10.5.6.2.3 Argentina: Injection Pen Market, by Type, 2019–2028 (US$ Million)
10.5.6.2.4 Argentina: Injection Pen Market, by Therapy, 2019–2028 (US$ Million)
10.5.6.2.5 Argentina: Injection Pen Market, by End User, 2019–2028 (US$ Million)
10.5.6.3 Rest of South & Central America: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
10.5.6.3.1 Overview
10.5.6.3.2 Rest of South & Central America: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
10.5.6.3.3 Rest of South & Central America: Injection Pen Market, by Type, 2019–2028 (US$ Million)
10.5.6.3.4 Rest of South & Central America: Injection Pen Market, by Therapy, 2019–2028 (US$ Million)
10.5.6.3.5 Rest of South & Central America: Injection Pen Market, by End User, 2019–2028 (US$ Million)
11. Global Injection Pen Market – Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Injection Pen Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Eli Lilly and Co
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Novo Nordisk AS
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Owen Mumford Ltd
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Sanofi SA
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Merck KGaA
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Haselmeier GmbH
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Gerresheimer AG
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Becton Dickinson and Co
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 AstraZeneca Plc
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Teva Pharmaceutical Industries Ltd
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Injection Pen Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 2. North America Injection Pen Market, by Therapy – Revenue and Forecast to 2028 (US$ Million)
Table 3. North America Injection Pen Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 4. US Injection Pen Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 5. US Injection Pen Market, by Therapy – Revenue and Forecast to 2028 (US$ Million)
Table 6. US Injection Pen Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 7. Canada Injection Pen Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 8. Canada Injection Pen Market, by Therapy – Revenue and Forecast to 2028 (US$ Million)
Table 9. Canada Injection Pen Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 10. Mexico Injection Pen Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 11. Mexico Injection Pen Market, by Therapy – Revenue and Forecast to 2028 (US$ Million)
Table 12. Mexico Injection Pen Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 13. Europe Injection Pen Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 14. Europe Injection Pen Market, by Therapy – Revenue and Forecast to 2028 (US$ Million)
Table 15. Europe Injection Pen Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 16. Germany Injection Pen Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 17. Germany Injection Pen Market, by Therapy – Revenue and Forecast to 2028 (US$ Million)
Table 18. Germany Injection Pen Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 19. UK Injection Pen Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 20. UK Injection Pen Market, by Therapy – Revenue and Forecast to 2028 (US$ Million)
Table 21. UK Injection Pen Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 22. France Injection Pen Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 23. France Injection Pen Market, by Therapy – Revenue and Forecast to 2028 (US$ Million)
Table 24. France Injection Pen Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 25. Italy Injection Pen Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 26. Italy Injection Pen Market, by Therapy – Revenue and Forecast to 2028 (US$ Million)
Table 27. Italy Injection Pen Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 28. Spain Injection Pen Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 29. Spain Injection Pen Market, by Therapy – Revenue and Forecast to 2028 (US$ Million)
Table 30. Spain Injection Pen Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 31. Rest of Europe Injection Pen Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 32. Rest of Europe Injection Pen Market, by Therapy – Revenue and Forecast to 2028 (US$ Million)
Table 33. Rest of Europe Injection Pen Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 34. Asia Pacific Injection Pen Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 35. Asia Pacific Injection Pen Market, by Therapy – Revenue and Forecast to 2028 (US$ Million)
Table 36. Asia Pacific Injection Pen Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 37. China Injection Pen Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 38. China Injection Pen Market, by Therapy – Revenue and Forecast to 2028 (US$ Million)
Table 39. China Injection Pen Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 40. Japan Injection Pen Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 41. Japan Injection Pen Market, by Therapy – Revenue and Forecast to 2028 (US$ Million)
Table 42. Japan Injection Pen Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 43. India Injection Pen Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 44. India Injection Pen Market, by Therapy – Revenue and Forecast to 2028 (US$ Million)
Table 45. India Injection Pen Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 46. South Korea Injection Pen Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 47. South Korea Injection Pen Market, by Therapy – Revenue and Forecast to 2028 (US$ Million)
Table 48. South Korea Injection Pen Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 49. Australia Injection Pen Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 50. Australia Injection Pen Market, by Therapy – Revenue and Forecast to 2028 (US$ Million)
Table 51. Australia Injection Pen Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 52. Rest of Asia Pacific Injection Pen Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 53. Rest of Asia Pacific Injection Pen Market, by Therapy – Revenue and Forecast to 2028 (US$ Million)
Table 54. Rest of Asia Pacific Injection Pen Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 55. Middle East & Africa Injection Pen Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 56. Middle East & Africa Injection Pen Market, by Therapy – Revenue and Forecast to 2028 (US$ Million)
Table 57. Middle East & Africa Injection Pen Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 58. South Africa Injection Pen Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 59. South Africa Injection Pen Market, by Therapy – Revenue and Forecast to 2028 (US$ Million)
Table 60. South Africa Injection Pen Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 61. Saudi Arabia Injection Pen Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 62. Saudi Arabia Injection Pen Market, by Therapy – Revenue and Forecast to 2028 (US$ Million)
Table 63. Saudi Arabia Injection Pen Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 64. UAE Injection Pen Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 65. UAE Injection Pen Market, by Therapy – Revenue and Forecast to 2028 (US$ Million)
Table 66. UAE Injection Pen Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 67. Rest of Middle East & Africa Injection Pen Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 68. Rest of Middle East & Africa Injection Pen Market, by Therapy – Revenue and Forecast to 2028 (US$ Million)
Table 69. Rest of Middle East & Africa Injection Pen Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 70. South & Central America Injection Pen Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 71. South & Central America Injection Pen Market, by Therapy – Revenue and Forecast to 2028 (US$ Million)
Table 72. South & Central America Injection Pen Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 73. Brazil Injection Pen Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 74. Brazil Injection Pen Market, by Therapy – Revenue and Forecast to 2028 (US$ Million)
Table 75. Brazil Injection Pen Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 76. Argentina Injection Pen Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 77. Argentina Injection Pen Market, by Therapy – Revenue and Forecast to 2028 (US$ Million)
Table 78. Argentina Injection Pen Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 79. Rest of South & Central America Injection Pen Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 80. Rest of South & Central America Injection Pen Market, by Therapy – Revenue and Forecast to 2028 (US$ Million)
Table 81. Rest of South & Central America Injection Pen Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 82. Recent Inorganic Growth Strategies in the Injection Pen Market
Table 83. Recent Organic Growth Strategies in the Injection Pen Market
Table 84. Glossary of Terms
LIST OF FIGURES
Figure 1. Injection Pen Market Segmentation
Figure 2. Injection Pen Market, by region
Figure 3. Global Injection Pen Market Overview
Figure 4. Disposable Segment Held Largest Share of Type Segment in Injection Pen Market
Figure 5. Asia Pacific Expected to Show Remarkable Growth During Forecast Period
Figure 6. Injection Pen Market, by Geography (US$ Million)
Figure 7. Global Injection Pen Market – Leading Country Markets (US$ Million)
Figure 8. Global Injection Pen Market – Industry Landscape
Figure 9. North America: PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. Asia Pacific: PEST Analysis
Figure 12. South & Central America: PEST Analysis
Figure 13. Middle East & Africa: PEST Analysis
Figure 14. Experts’ Opinion
Figure 15. Injection Pen Market: Impact Analysis of Drivers and Restraints
Figure 16. Global Injection Pen Market – Revenue Forecast and Analysis – 2020–2028
Figure 17. Global Injection Pen Market, by Geography – Forecast and Analysis (2021–2028)
Figure 18. Market Positioning of Key Players in Injection Pen Market
Figure 19. Injection Pen Market Revenue Share, by Type 2021 & 2028 (%)
Figure 20. Disposable Injection Pens: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Reusable Injection Pens: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Global Injection Pen Market, by Therapy 2021 & 2028 (%)
Figure 23. Diabetes Therapy: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Growth Hormone Therapy: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Autoimmune Diseases Therapy: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Fertility Therapy: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Cancer Therapy: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Other Therapies: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Injection Pen Market Revenue Share, by End User 2021 & 2028 (%)
Figure 30. Home Care: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Hospitals & Clinics: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32. Others: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
Figure 33. North America: Injection Pen Market, by Key Country – Revenue (2022) (US$ Million)
Figure 34. North America Injection Pen Market Revenue and Forecast to 2028 (USD Million)
Figure 35. US: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
Figure 36. Canada: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
Figure 37. Mexico: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
Figure 38. Europe: Injection Pen Market, by Key Country – Revenue (2021) (US$ Million)
Figure 39. Europe Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
Figure 40. Europe: Injection Pen Market, by Country, 2021 & 2028 (%)
Figure 41. Germany: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
Figure 42. UK: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
Figure 43. France: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
Figure 44. Italy: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
Figure 45. Spain: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
Figure 46. Rest of Europe: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
Figure 47. Asia Pacific: Injection Pen Market, by Key Country – Revenue (2021) (US$ Million)
Figure 48. Asia Pacific Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
Figure 49. China: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
Figure 50. Japan: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
Figure 51. India: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
Figure 52. South Korea: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
Figure 53. Australia: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
Figure 54. Rest of Asia Pacific: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
Figure 55. Middle East & Africa: Injection Pen Market, by Key Country – Revenue (2022) (US$ Million)
Figure 56. Middle East & Africa Injection Pen Market Revenue and Forecast to 2028 (USD Million)
Figure 57. South Africa: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
Figure 58. Saudi Arabia: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
Figure 59. UAE: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
Figure 60. Rest of Middle East & Africa: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
Figure 61. South & Central America: Injection Pen Market, by Key Country – Revenue (2022) (US$ Million)
Figure 62. South & Central America Injection Pen Market Revenue and Forecast to 2028 (USD Million)
Figure 63. Brazil: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
Figure 64. Argentina: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
Figure 65. Rest of South & Central America: Injection Pen Market – Revenue and Forecast to 2028 (US$ Million)
Figure 66. Growth Strategies in the Injection Pen Market
● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the injection pen market.
● Highlights key business priorities in order to assist companies to realign their business strategies.
● The key findings and recommendations highlight crucial progressive industry trends in the global injection pen market, thereby allowing players across the value chain to develop effective long-term strategies.
● Develop/modify business expansion plans by using substantial growth offerings in developed and emerging markets.
● Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
● Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution
The List of Companies – Injection Pens Market
● Novo Nordisk A/S
● Novartis AG
● Eli Lilly
● Merck KGaA
● Wilhelm Haselmeier GmbH & Co. KG
● Astrazeneca
● F.Hoffman-La-Roche
● BD
● Pfizer
● Teva Pharmaceutical Industries Ltd.
Disposable Segment to Account for Larger Share in Injection Pen Market During 2022–2028
According to the research study titled “The Injection Pen Market Forecast to 2028 – Global Analysis – by Type, Therapy, and End User,” the market is expected to grow from US$ 37,261.35 million in 2021 to US$ 60,332.97 million by 2028; it is expected to register a CAGR of 7.14% from 2022 to 2028. The report highlights the key factors driving the market growth and prominent players with their developments in the market.
Growth of Strategic Developments
The injection pen market is characterized by the presence of various market players. To increase their market share, market players take up various strategies such as product launches, regional expansion, and technological advancements. Injection pens are more involved in continuous innovation and technological advances, leading to increased acceptance among industry players. Leading players invest in R&D to develop advanced technologies and gain more revenue.
A few recent developments related to injection pen are mentioned below:
In May 2022, FDA approved Lilly’s Mounjaro injection, the first and only glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist for the treatment of type 2 diabetes in adults. Mounjaro is available in six doses (2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg) and comes in Lilly’s well-established auto-injector pen with a pre-attached, hidden needle.
In January 2022, SHL Medical’s partnered with Innovation Zed for connected pen injector solutions. It launched InsulCheck DOSE, a connected add-on device that transforms traditional pen injectors into smart solutions to support the monitoring of disease management regimen.
In November 2021, Sanofi and Roche partnered to work together in France to increase the adoption of a connected add-on for disposable insulin pens. The partners will jointly develop a scientific educational program aimed at physicians and pharmacists.
In September 2021, BIOCORP and Novo Nordisk strengthened their partnership with a new agreement on Mallya Smart Sensor with Novo Nordisk FlexTouch insulin pens. A smart sensor called Mallya attaches directly to Novo Nordisk FlexTouch insulin pens. With Mallya, patients using FlexTouch pens will be able to capture and record daily insulin injection data, which includes insulin units, as well as date and time of the drug administration. Based on the agreement, Novo Nordisk will be commercializing Mallya in Japan from the first half of 2023.
In May 2021, Lilly collaborated internationally with leading diabetes technology companies to integrate connected insulin pen solutions for people with diabetes. The company signed strategic international agreements with four companies—DexCom, Inc.; Glooko Inc.; myDiabby Healthcare; and Roche—to advance connected solutions and streamline care for people suffering from diabetes.
Therefore, all the above-mentioned recent developments are driving the growth of injection pen market.
Market Opportunities
Increase in Biologics Patent Expiry and Use of Biosimilars
Biologics are widely developed for treating chronic disorders such as cancer, multiple sclerosis, and diabetes. These drugs are unique in their own way and manufacturers own patents of 20 years for manufacturing and distributing such drugs. As most of the patents are either expired or on the verge of expiry, other market players have begun launching their own version of such drugs, i.e., biosimilars. Biosimilars (generic drugs that are low priced and are preferred by the government and insurance companies) have gained tremendously traction over the past few years over the original biologics. The pharmaceutical market players are promoting the adoption of biosimilars, which further creates the demand for injection pens for its delivery. As per AJMC, a total of 40 biosimilars were approved and 25 new biosimilars were launched in the US till December 2022. Furthermore, there has been significant use of injectables on a large scale owing to prompt response, thus generating the demand for injection pens for safe.
Furthermore, the manufacturers of injection pen are constantly providing training for the proper use of injection pens to avoid associated danger such as needle stick injuries and hyperglycemia, which is expected to further create opportunities for injection pen market. For instance, Noble, a Aptar Pharma company is the global leader in the medical device training solution which improves the patient experience and outcomes by developing patient-centric drug delivery training devices including injection pen, autoinjector, prefilled syringe and others. Therefore, increased use of biosimilars, patent expiry, and increased use of injectables are likely to create ample opportunity for the growth of injection pen market in the coming years.
Based on type, the injection pen market is bifurcated into disposable and reusable injection pen. In 2021, the disposable segment held a larger share of the market and is expected to register a higher CAGR during the forecast period. By therapy, the market is segmented as diabetes therapy, growth hormone therapy, autoimmune diseases therapy, fertility therapy, cancer therapy, and other therapies. The other therapies segment held the largest market share in 2021 and is likely to continue its dominance during the forecast period. In terms of end user, the market is divided into hospital & clinics, home care, and others. The home care segment held the largest market share in 2021 and will likely continue its dominance during the forecast period.
Eli Lilly and Co, Novo Nordisk AS, Owen Mumford Ltd, Sanofi SA, Merck KGaA, Haselmeier GmbH, Gerresheimer AG, Becton Dickinson and Co, AstraZeneca Plc, and Teva Pharmaceutical Industries Ltd. are among the leading companies operating in the global injection pen market.
Based on geography, the global injection pen market is primarily segmented into North America, Europe, Asia Pacific, Middle East & Africa (MEA), and South & Central America. The North America injection pen market is further segmented into the US, Canada, and Mexico. The Europe injection pen market is sub segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. The Asia Pacific injection pen market is sub segmented into China, Japan, India, Australia, South Korea, and the Rest of APAC. The injection pen market in the MEA is further segmented into South Africa, Saudi Arabia, the UAE, and the Rest of MEA. The South & Central America injection pen market is sub segmented into Brazil, Argentina, and the Rest of South & Central America.
We provide our clients with insightful market research reports and competitive intelligence that helps them stay ahead of the curve.
Business-era specializes in accelerating growth and providing improved brand value to organizations in the competitive market. We synergize with organizations to connect clients and businesses.